<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180110038298N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-02-23</date_registration>
      <primary_sponsor>Zahedan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of oropharyngeal decontamination by topical antibiotics on the ventilator associated pneumonia</public_title>
      <acronym></acronym>
      <scientific_title>Effect of oropharyngeal decontamination by topical antibiotics on  incidence of ventilator-associated pneumonia  in hospitalized traumatic patients in intensive care units</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-02-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28891</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: At first, patients will be selected from eligible people with valid entry criteria and then assigned to two groups of intervention and control in a simple random manner. The randomization will be as follows: 100 cards (corresponding to the estimated sample size) are colored with green and orange colors. Green cards are assigned to the control group and 50 red cards for the intervention group. Cards are arranged randomly. After referring to the department and examining the patient and determining his eligibility, depending on the color of card is assigned to each patient, the control group or intervention is determined, Blinding description: Only researcher will be aware of the randomness. In order to blindness, a nurse familiar with critical care , after education about the method of mouthwash and the use of tools, recruitment as a partner  who is not familiar with how to allocate patients in the intervention or control group. The solution is uniform and looks similar to the drug solution is provided and give to the nurse for the control group. Proficient collaborator and Samples analyzer lab will not be aware of the randomness.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Ventilator associated pneumonia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: On the first day of intubation, oral washing perform four times a day, with normal saline solution. On the second day of intubation, collect the initial sample of the pharyngeal and tracheal secretions and sent to the laboratory for culture, then with a 2% concentration of poly-myxin, nystatin and neomycin, prepared and combined by investigator administer with a syringe on the oral cavity and the lips are used in such a way that the mucus is impregnated with it. This action is repeated four times after normal oral saline mouthwash. The duration of the study is at least three days, and if the terms of exclusion are not established, it lasts for a maximum of five days. At the end of the fifth day, the throat and tracheal secretions are again sampled and the intervention is completed. Intervention 2: Control group: On the first day of intubation, mouth washing is perform four times in day, with normal saline solution. On the second day, first sampled the tracheal and pharyngeal discharge, then, daily after each oral wash with normal saline, a solution with the appearance and volume of the same basic solution used by the researcher with a syringe in the mouth and lips, is applied in such a way that the mucosa is impregnated. This action is repeated four times. The duration of the study is at least three days, and if the terms of exclusion are not established, it lasts for a maximum of five days. At the end of the fifth day, the throat and tracheal secretions are again sampled and the intervention is completed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Morteza Barani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 1, Behdasht Blvd.,Mashahir square, Faculty of Nursing and Midwifery</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816743463</zip>
        <telephone>+98 54 3344 2482</telephone>
        <email>mimbaran@yahoo.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Aliakbar Keykha</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 1, Behdasht Blvd.,Mashahir square, Faculty of Nursing and Midwifery</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816743463</zip>
        <telephone>+98 54 3344 2482</telephone>
        <email>aliakbar.keykha@gmail.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The age of the patient is between 18 and 65 years
Perform intubation in the first 24 hours and stay at least 72 hours
Clinical pulmonary infection score less than 6 at the time of arrival
Oral hygiene assessment checklist score 10 or less
GCS less than 9</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>damage to the mouth, jaw and face
cancer and diabetes and chronic obstructive pulmonary disease
immunosuppression due to certain medications or diseases
history of broad-based antibiotic therapy in the past 3 months
perform a cardiopulmonary resuscitation process</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J95.851</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Ventilator associated pneumonia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: On the first day of intubation, oral washing perform four times a day, with normal saline solution. On the second day of intubation, collect the initial sample of the pharyngeal and tracheal secretions and sent to the laboratory for culture, then with a 2% concentration of poly-myxin, nystatin and neomycin, prepared and combined by investigator administer with a syringe on the oral cavity and the lips are used in such a way that the mucus is impregnated with it. This action is repeated four times after normal oral saline mouthwash. The duration of the study is at least three days, and if the terms of exclusion are not established, it lasts for a maximum of five days. At the end of the fifth day, the throat and tracheal secretions are again sampled and the intervention is completed.</i_keyword>
      <i_keyword>Control group: On the first day of intubation, mouth washing is perform four times in day, with normal saline solution. On the second day, first sampled the tracheal and pharyngeal discharge, then, daily after each oral wash with normal saline, a solution with the appearance and volume of the same basic solution used by the researcher with a syringe in the mouth and lips, is applied in such a way that the mucosa is impregnated. This action is repeated four times. The duration of the study is at least three days, and if the terms of exclusion are not established, it lasts for a maximum of five days. At the end of the fifth day, the throat and tracheal secretions are again sampled and the intervention is completed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The incidence of ventilator-dependent pneumonia. Timepoint: At the beginning of the study, before the intervention, and daily until the end of the intervention. Method of measurement: Clinical pulmonary infection score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Microorganisms grown from pharyngeal  and tracheal secretion samples. Timepoint: The first day of the study before the intervention and 5. Method of measurement: Perform culturing in the laboratory by a laboratory collaborator.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zahedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-12-24</approval_date>
        <contact_name>Ethics committee of zahedan university of medical Sciences</contact_name>
        <contact_address>NO. 1 , Daneshgah Ave., Hesabi Squ., Pardis complex , university of medical sciences Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
